Overcoming resistance to KRAS inhibition in KRAS/PIK3CA co-mutated colorectal cancer

Oncogenic alleles of KRAS drive colorectal cancers (CRC) growth and are associated with worse disease outcomes. Despite potent allele-specific and pan-RAS inhibitors targeting now in clinical test, CRC patients are not experiencing the same therapeutic benefit as patients with other cancers. PI3-Kinase (PI3K) is a direct RAS effector and is co-mutated in about 45% of CRC cases, raising the possibility that frequent oncogenic PI3K mutations contribute to the limited benefit of KRAS inhibition in CRC. Using isogenic colorectal cancer cells engineered to harbor either of the two most common activating PIK3CA mutations, we show that oncogenic PI3K promotes resistance to the pan-RAS inhibitor daraxonrasib (RMC-6236). Global phosphoproteomic profiling revealed that PIK3CA-mutant cells undergo a distinct adaptive response to RAS inhibition, characterized by sustained PI3K-AKT signaling and extensive remodeling of pathways controlling cell-cell adhesion and junction signaling, alongside suppression of apoptotic signaling. Combined RAS and PI3Kα inhibition overcame this resistance, suppressed signaling through both pathways and induced apoptosis in PIK3CA-mutant cells. Together, these findings identify oncogenic PIK3CA as a determinant of resistance to RAS inhibition in KRAS-mutant colorectal cancer and provide a mechanistic rationale for combined KRAS and PI3Kα inhibition in KRAS/PIK3CA co-mutant tumors.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-12
DOI
https://doi.org/10.64898/2026.11.10.765758
Primary Topic
Protein Kinase Regulation and GTPase Signaling
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Overcoming resistance to KRAS inhibition in KRAS/PIK3CA co-mutated colorectal cancer

Raymond Xu, Kasturi Bala Nayak, Nevan J. Krogan, John Dozier Gordan et al.
bioRxiv (Cold Spring Harbor Laboratory)
Protein Kinase Regulation and GTPase Signaling
preprint

Overcoming resistance to KRAS inhibition in KRAS/PIK3CA co-mutated colorectal cancer

Raymond Xu, Kasturi Bala Nayak, Nevan J. Krogan, John Dozier Gordan, Rigney E. Turnham, Pornparn Kongpracha, Lucille Ferret, Danielle L. Swaney, José L Montaño, Clarise G Rivera
preprint en

Abstract

Oncogenic alleles of KRAS drive colorectal cancers (CRC) growth and are associated with worse disease outcomes. Despite potent allele-specific and pan-RAS inhibitors targeting now in clinical test, CRC patients are not experiencing the same therapeutic benefit as patients with other cancers. PI3-Kinase (PI3K) is a direct RAS effector and is co-mutated in about 45% of CRC cases, raising the possibility that frequent oncogenic PI3K mutations contribute to the limited benefit of KRAS inhibition in CRC. Using isogenic colorectal cancer cells engineered to harbor either of the two most common activating PIK3CA mutations, we show that oncogenic PI3K promotes resistance to the pan-RAS inhibitor daraxonrasib (RMC-6236). Global phosphoproteomic profiling revealed that PIK3CA-mutant cells undergo a distinct adaptive response to RAS inhibition, characterized by sustained PI3K-AKT signaling and extensive remodeling of pathways controlling cell-cell adhesion and junction signaling, alongside suppression of apoptotic signaling. Combined RAS and PI3Kα inhibition overcame this resistance, suppressed signaling through both pathways and induced apoptosis in PIK3CA-mutant cells. Together, these findings identify oncogenic PIK3CA as a determinant of resistance to RAS inhibition in KRAS-mutant colorectal cancer and provide a mechanistic rationale for combined KRAS and PI3Kα inhibition in KRAS/PIK3CA co-mutant tumors.

bioRxiv (Cold Spring Harbor Laboratory)
University of California, San Francisco (US)
Good health and well-being
Protein Kinase Regulation and GTPase Signaling
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon